Trial Site Detail

 

Drug:	IPI-504
Trial:	Study of IPI-504 in GIST patients following failure of at least imatinib and sunitinib
Conditions:	Gastrointestinal Stromal Tumor
Trial Status:	Terminated

 

New Bern Cancer Center       New Bern , NC 28562 USA

 

Principal Investigator:	Rick Gorman Jr.M.D.
Contact:	Jenifer Haggard 252-638-0422 jenifer.haggard@quintiles.com
Activation Status of this Site:	Closed
Notes about this Site:
New Bern Cancer Center Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.